Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas-Reference-Cited by-同舟云学术

Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas

Published:2022-01-20 Issue: Volume: Page:
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Noro Rintaro¹^ORCID,Honda Kazufumi²³^ORCID,Nagashima Kengo⁴^ORCID,Motoi Noriko⁵⁶^ORCID,Kunugi Shinobu⁷,Matsubayashi Jun⁸,Takeuchi Susumu¹⁹,Shiraishi Hideaki²,Okano Tetsuya¹⁹,Kashiro Ayumi²³,Meng Xue²³,Yoshida Yukihiro¹⁰,Watanabe Shunichi¹⁰,Usuda Jitsuo¹¹,Inoue Tatsuya¹¹,Wilber Huang¹²,Ikeda Norihiko⁹,Seike Masahiro¹,Gemma Akihiko¹,Kubota Kaoru¹

Affiliation:

1. Department of Pulmonary Medicine and Oncology Graduate School of Medicine Nippon Medical School Tokyo Japan

2. Department of Biomarkers for Early Detection of Cancer National Cancer Center Research Institute Tokyo Japan

3. Department of Bioregulation Graduate School of Medicine Nippon Medical School Tokyo Japan

4. Research Center for Medical and Health Data Science Keio University Hospital Tokyo Japan

5. Department of Diagnostic Pathology National Cancer Center Hospital Tokyo Japan

6. Department of Pathology Saitama Cancer Center Saitama Japan

7. Department of Analytic Human Pathology Graduate School of Medicine Nippon Medical School Tokyo Japan

8. Department of Anatomical Pathology Tokyo Medical University Tokyo Japan

9. Department of Surgery Tokyo Medical University Tokyo Japan

10. Department of Thoracic Surgery National Cancer Center Hospital Tokyo Japan

11. Department of Thoracic Surgery Graduate School of Medicine Nippon Medical School Tokyo Japan

12. Abnova Taipei City Taiwan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15228

Reference28 articles.

1. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw P;J Thorac Oncol,2007

2. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB‐IIIA non‐small‐cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard J‐Y;Lancet Oncol,2006

3. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non‐small‐cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups;Strauss GM;J Clin Oncol,2008

4. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I‐IIIA resectable non small‐cell lung cancer guideline;Pisters KMW;J Clin Oncol,2007

5. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade;Sawabata N;J Thorac Oncol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High MICAL-L2 promotes cancer progression and drug resistance of renal clear cell carcinoma cell via stabilization of ACTN4 and following vimentin expression;2024-06-25

2. ACTN4-dependent regulation of double-strand DNA break repair is independent of NF-Kb activity;Цитология;2024-06-05

3. α-Actinin-4-Dependent Regulation of DNA Break Repair Is Not Dependent on NF-kB Activity;Cell and Tissue Biology;2024-06

4. Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability;Cancers;2022-09-07